Quick Answer
Merck & Co., Inc. reported Stockholders Equity of $52.61 billion for fiscal year 2025.
Merck & Co., Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $52.61B | +13.6% |
| 2024 | $46.31B | +23.2% |
| 2023 | $37.58B | -18.3% |
| 2022 | $45.99B | +20.4% |
| 2021 | $38.18B | +50.8% |
| 2020 | $25.32B | -2.3% |
| 2019 | $25.91B | -3.0% |
| 2018 | $26.70B | -22.2% |
| 2017 | $34.34B | -14.3% |
| 2016 | $40.09B | -10.3% |
| 2015 | $44.68B | -8.2% |
| 2014 | $48.65B | -2.2% |
| 2013 | $49.77B | -6.1% |
| 2012 | $53.02B | -2.7% |
| 2011 | $54.52B | +0.3% |
| 2010 | $54.38B | -7.9% |
| 2009 | $59.06B | +214.8% |
| 2008 | $18.76B | -8.9% |
| 2007 | $20.59B | +3.1% |
| 2006 | $19.97B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.85B | +16.5% | +5.8% |
| June 30, 2025 | $48.99B | +12.4% | +1.4% |
| March 31, 2025 | $48.34B | +19.7% | +4.4% |
| December 31, 2024 | $46.31B | +23.2% | +4.1% |
| September 30, 2024 | $44.50B | +7.9% | +2.1% |
| June 30, 2024 | $43.58B | +12.6% | +8.0% |
| March 31, 2024 | $40.36B | -13.8% | +7.4% |
| December 31, 2023 | $37.58B | -18.3% | -8.9% |
- Merck & Co., Inc. showed an increase of +13.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2006–2025 period, Merck & Co., Inc.’s stockholders equity has grown by 163.5% (from $19.97 billion to $52.61 billion).
- The most recent figure is from Merck & Co., Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: